BioTissue Technologies AG
Ad hoc-Service: BioTissue AG english
Ad hoc announcement transmitted by DGAP.
The issuer has the sole responsibility of this announcement.
——————————————————————————–
BioTissue Technologies concludes distribution cooperation agreement with Baxter
BioTissue Technologies AG (SIN 618061), the Freiburg-based company listed on the
Neuer Markt segment of the Frankfurt Stock Exchange, has concluded a
distribution cooperation agreement with the Biosurgery Unit of Baxter Hyland
Immuno for its autologous skin replacement product, BioSeed-S. Baxter
International Inc. with its affiliates is an internationally acting health care
company with annual sales of around seven billion US dollars. The cooperation
agreement includes production of BioSeed-S by BioTissue and exclusive worldwide
distribution by Baxter.
The collaboration between BioTissue and Baxter comes into immediate effect in
Germany. In parallel, the two companies are currently preparing to launch
BioSeed-S in other countries inside and outside of Europe.
Sales revenues from BioSeed-S will be split between both partners. The costs of
any necessary investments will be treated in the same way.
Baxter provides the requisite sales muscle and many years of direct contact with
customers in the field of wound treatment as well as in surgery. In 2001,
BioTissue and its specialist field sales team will focus on launching three new
products.
For BioTissue, the collaboration with Baxter represents the first step in
arranging a series of product-specific partnerships in the field of distribution
Similar partnerships already exist with regard to R&D.
For further information contact: BioTissue Technologies AG, Martin Braendle,
Investor Relations Manager, Phone: +49-761-7675110, E-Mail: braendle@biotissue-
tec.com, Internet: www.biotissue-tec.com
end of ad hoc announcement, (c) DGAP 18.04.2001
——————————————————————————–
WKN: 618061; Index:
Listed: Neuer Markt in Frankfurt;
Freiverkehr in Berlin, Bremen, Düsseldorf, Hamburg, Hannover, München und
Stuttgart
180836 Apr 01
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden